The effect of race of patients with coronary heart disease on the provider choice of aspirin, beta-blockers, and ACE-inhibitors in ambulatory care
The purpose of this study was to examine the effect of race as a predictor in the treatment of heart disease. The study measured the effect of race on the evidence-based recommendations regarding aspirin, beta-blockers, and ACE-inhibitors in the management of coronary heart disease in ambulatory care, using secondary data analysis of the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Location and type of facility were also examined as possible predictors of care. Although disparities in hospital-based studies comparing Blacks and Whites have been well documented, little is known about race and coronary care in ambulatory care settings. This study showed Blacks received higher proportions of the evidence-based medications than Whites. The implications may mean racial/ethnic disparities of care favor better treatment for Blacks in ambulatory settings and Blacks receive low cost and efficient treatment. However; unlike Whites, they may not be subsequently referred for cardiac catheterization and angioplasty.